Your browser doesn't support javascript.
loading
Author Correction: Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.
Bussiere, Dirksen E; Xie, Lili; Srinivas, Honnappa; Shu, Wei; Burke, Ashley; Be, Celine; Zhao, Junping; Godbole, Adarsh; King, Dan; Karki, Rajeshri G; Hornak, Viktor; Xu, Fangmin; Cobb, Jennifer; Carte, Nathalie; Frank, Andreas O; Frommlet, Alexandra; Graff, Patrick; Knapp, Mark; Fazal, Aleem; Okram, Barun; Jiang, Songchun; Michellys, Pierre-Yves; Beckwith, Rohan; Voshol, Hans; Wiesmann, Christian; Solomon, Jonathan M; Paulk, Joshiawa.
Afiliação
  • Bussiere DE; Novartis Institutes for Biomedical Research, Emeryville, CA, USA. dirksen.bussiere@novartis.com.
  • Xie L; Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
  • Srinivas H; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Shu W; Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
  • Burke A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Be C; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Zhao J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Godbole A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • King D; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Karki RG; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Hornak V; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Xu F; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Cobb J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Carte N; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Frank AO; Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
  • Frommlet A; Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
  • Graff P; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Knapp M; Novartis Institutes for Biomedical Research, Emeryville, CA, USA.
  • Fazal A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Okram B; Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA.
  • Jiang S; Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA.
  • Michellys PY; Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA.
  • Beckwith R; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Voshol H; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Wiesmann C; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Solomon JM; Novartis Institutes for Biomedical Research, Cambridge, MA, USA. jonathan.solomon@novartis.com.
  • Paulk J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA. josh.paulk@novartis.com.
Nat Chem Biol ; 16(3): 361, 2020 Mar.
Article em En | MEDLINE | ID: mdl-31942047
ABSTRACT
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Chem Biol Assunto da revista: BIOLOGIA / QUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Chem Biol Assunto da revista: BIOLOGIA / QUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos